Neuraxis Inc (NRXS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Sales | 532 | 478 | 646 | 805 | 0 |
| Cost of Goods | 72 | 67 | 68 | 96 | N/A |
| Gross Profit | 459 | 410 | 578 | 709 | N/A |
| Operating Expenses | 2,160 | 3,500 | 1,764 | 1,701 | 0 |
| Operating Income | -1,628 | -3,022 | -1,118 | -896 | N/A |
| Interest Expense | 17 | 103 | 195 | 165 | 0 |
| Other Income | 53 | -5,501 | -923 | -1,113 | 0 |
| Pre-tax Income | -1,592 | -8,625 | -2,236 | -2,173 | 0 |
| Net Income Continuous | -1,592 | -8,625 | -2,236 | -2,173 | N/A |
| Net Income | $-1,592 | $-8,625 | $-2,236 | $-2,173 | $N/A |
| EPS Basic Total Ops | 0.27 | -2.38 | -1.21 | -1.18 | N/A |
| EPS Basic Continuous Ops | 0.08 | -2.38 | -1.12 | -1.08 | N/A |
| EPS Diluted Total Ops | 0.27 | -2.38 | -1.21 | -1.18 | N/A |
| EPS Diluted Continuous Ops | 0.08 | -2.38 | -1.12 | -1.08 | N/A |
| EBITDA(a) | $-1,618 | $-1,681 | $-219 | $1,776 | $N/A |